Skip to main content
Onxeo logo

Onxeo — Investor Relations & Filings

Ticker · ALONX ISIN · FR0010095596 LEI · 96950018AS30IUG0V528 PA Manufacturing
Open in API
Filings indexed 661 across all filing types
Latest filing 2023-03-14 Report Publication Anno…
Country FR France
Listing PA ALONX

About Onxeo

https://www.onxeo.com/

Valerio Therapeutics, formerly Onxeo, is a biotechnology company developing next-generation precision-guided therapies for complex and underserved diseases. The company's core technology is its proprietary V-Body platform, which is based on two fully synthetic single-domain antibody (sdAb) libraries. This platform is engineered to create advanced drug conjugates that enable deep tissue penetration and highly precise therapeutic delivery. By integrating innovative target identification, antibody engineering, and cutting-edge linker and payload technologies, Valerio Therapeutics aims to develop treatments with superior efficacy and target engagement. The company's strategy involves advancing its therapeutic candidates to key development milestones before pursuing strategic partnerships for co-development and out-licensing.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is a short press release dated March 14, 2023, announcing future dates for two key corporate events: the publication of the 2022 annual results (April 14, 2023) and the date of the Annual General Meeting (AGM) (June 6, 2023). Since the document is short (under 5,000 characters) and its primary function is to announce *when* reports and meetings will occur rather than containing the full content of those reports or the meeting minutes, it fits the definition of a Report Publication Announcement (RPA). Specifically, it announces the publication of the annual results and the date of the AGM, which is closely related to AGM materials (AGM-R). However, the core action here is the announcement of the publication schedule, making RPA the most precise fit based on the 'MENU VS MEAL' rule.
2023-03-14 French
Inside Information / Other news releases
Report Publication Announcement Classification · 1% confidence The document is a press release dated March 14, 2023, announcing future dates for two key corporate events: the publication of the 2022 full-year results (April 14, 2023) and the holding of the annual general meeting (June 6, 2023). Since the document is an announcement *about* future reports and meetings, rather than the reports or meeting materials themselves, it fits the definition of a Report Publication Announcement (RPA). It explicitly states when reports will be published and when the AGM will occur, which aligns perfectly with the RPA definition (announcement regarding the timing, release, or publication of company reports). It is not the 10-K (full report), ER (earnings release), or AGM-R (meeting materials).
2023-03-14 English
Inside Information / Other news releases
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly reports on the results and proceedings of an 'Extraordinary General Meeting (EGM)' held on February 6, 2023. It details that the meeting adopted all resolutions and mentions that the consolidated result of the vote will be made available. This directly relates to the outcome of a shareholder vote following a general meeting. Therefore, the most appropriate classification is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it mentions AGM information, the specific content focuses on the voting results of the EGM.
2023-02-06 English
Informations privilégiées / Autres communiqués
AGM Information Classification · 1% confidence The document is explicitly titled "Onxeo : compte rendu de l'assemblée générale extraordinaire du 6 février 2023" (Onxeo: minutes/report of the extraordinary general meeting of February 6, 2023). It details that the Extraordinary General Meeting (AGE) was held, deliberated, and adopted all resolutions. It also mentions where the voting results and minutes will be available. This content directly relates to the proceedings and outcomes of a shareholder meeting. Therefore, the most appropriate classification is AGM Information (AGM-R). Although it mentions the voting results will be available later, the primary content is the report/summary of the meeting itself.
2023-02-06 French
Inside Information / Other news releases
Report Publication Announcement Classification · 1% confidence The document is titled "Onxeo Announces its Financial Agenda for 2023" and explicitly lists future dates for key corporate events like the Extraordinary General Meeting, Full-year 2022 results, Annual General Meeting, and Half-year 2023 results. This is a forward-looking announcement detailing the schedule of future corporate reports and meetings, rather than the reports themselves (like 10-K or ER). Since it is an announcement about the timing/release of future reports, it fits best under Report Publication Announcement (RPA). It is not a general regulatory filing (RNS) because RPA is more specific for scheduling announcements.
2023-01-27 English
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is titled "Onxeo annonce son calendrier financier 2023" (Onxeo announces its 2023 financial calendar) and explicitly lists future dates for key financial events like the Annual General Meeting (AGM), Annual Results, First Half Results, and an Extraordinary General Meeting. This document is an announcement detailing *when* future reports or meetings will occur, rather than being the report itself (like 10-K, IR, or ER). Since it is an announcement about the publication schedule of company reports, it fits best under the category for announcing report publication timing, which is Report Publication Announcement (RPA). The document length (4584 chars) is short enough to suggest it is an announcement rather than a full, detailed report.
2023-01-27 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.